Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.The project
Minneapolis-based Medtronic is spending $31 million to expand its European headquarters and production facilities in the Swiss state of Vaud. Medtronic supplies equipment for treating cardiac, vascular, neurologic, and spinal conditions.
The project brings Medtronics total investment in its Swiss facilities to $67 million. The expansion will add 200 new jobs, double Medtronics production capacity, provide a training center, and add room for administrative personnel, said Barry Wilson, Medtronics president of Europe, Africa, and the Middle East.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.